MarketInOut Stock Screener Log In | Sign Up

Benitec Biopharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Benitec Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization304.93 mln
Float34.01 mln
Earnings Date11/16/2026

Piotroski F-Score

4 / 9
Borderline

1-Year Forecast

23.29
Transformational upside

Relative Strength

89 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

ROE

-30.83
Deeply negative

ROA

-30.13
Deeply negative

Business Description

Benitec Biopharma is a clinical-stage company working to create new treatments based on genetic medicine. Using its proprietary platform, the company develops therapies that can switch off harmful genes while simultaneously introducing healthy replacement genes ? all through a single treatment. Its lead program targets oculopharyngeal muscular dystrophy, a condition that causes progressive difficulty swallowing. The company operates from its headquarters in Hayward, California.

Key Fundamentals

EPS-0.98
ROE-30.83
ROIC-2,184
ROA-30.13
Interest Cover21.32
EBITDA, mln-45.06
EV / EBITDA-2.74
EV / EBIT-2.71

Quote Details

Last 8.74
Change -0.09 (-1.02%)
Open 8.80
Volume 135,485
Turnover 1,184,139
Average Volume 193,778

Financial Ratios

Leverage Ratio1.03
Current Ratio34.00
Price / Book1.69
Price / Tangible Book1.69
Debt / Equity0.00

Financial Strength

Piotroski F-Score 4 / 9
1-Year Target Price23.29
Short Ratio9.77
Short % of Float9.99

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.04% 74 / 100   
1 Month -8.77% 31 / 100   
2 Months -24.53% 19 / 100   
6 Months -26.86% 23 / 100   
1 Year -45.95% 20 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog